Retraction notices

Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway

Type

Retraction

Notice date

3/16/2026 0:00

Journal

Cancer Chemotherapy and Pharmacology

Publisher

Springer - Nature Publishing Group

Notice DOI

10.1007/s00280-026-04874-0

Original paper DOI

10.1007/s00280-021-04380-5

Reasons

• Concerns/Issues about Image
• Duplication of/in Image
• Euphemisms for Duplication
• Investigation by Journal/Publisher
• Lack of IRB/IACUC Approval and/or Compliance
• Unreliable Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• Cancer Chemotherapy and Pharmacology